NM23-H1 Polyclonal Antibody

NME1 (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by NME1) and 'B' (encoded by NME2) isoforms. Mutations in NME1 have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for NME1. Co-transcription of NME1 and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product.

The NM23-H1 Polyclonal Antibody is a highly specific and sensitive antibody that has been designed for use in various research applications. This antibody has been produced using high-quality materials and advanced techniques to ensure its purity and effectiveness. It is a polyclonal antibody that has been raised against the NM23-H1 protein, which is a nucleoside diphosphate kinase that plays a crucial role in cell proliferation, differentiation, and metastasis.

The NM23-H1 Polyclonal Antibody has been extensively validated for use in Western blotting, immunohistochemistry, and immunofluorescence assays. It is suitable for use in a wide range of research applications, including cancer research, cell biology, and developmental biology.

This antibody is available in various sizes and formats to meet the specific needs of different research projects. With its high specificity and sensitivity, the NM23-H1 Polyclonal Antibody is an essential tool for researchers who are studying the role of NM23-H1 in various biological processes.